Patents by Inventor Julia DUBOIS

Julia DUBOIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Attenuated virus strain and use thereof as a vaccine
    Patent number: 11504424
    Abstract: The present invention relates to an attenuated virus strain derived from a human metapneumovirus strain comprising the genome sequence represented by sequence SEQ ID NO. 1, said attenuated strain comprising one or more genetic modifications of said sequence SEQ ID NO. 1 attenuating the virulence of said strain.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: November 22, 2022
    Assignees: UNIVERSITE CLAUDE BERNARD LYON 1, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), ECOLE NORMALE SUPERIEURE DE LYON, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE LAVAL
    Inventors: Manuel Rosa-Calatrava, Guy Boivin, Julia Dubois, Mario Andres Pizzorno, Olivier Terrier, Marie-Eve Hamelin, Marie-Helene Cavanagh
  • PRODUCTION OF VIRAL VACCINES ON AN AVIAN CELL LINE
    Publication number: 20220054618
    Abstract: The present invention relates to the use of the immortalised cell line ECACC 09070703, deposited on 7 Jul. 2009 at the European Collection of Authenticated Cell Cultures (ECACC, Salisbury, UK) under the number 09070703, for the production of a viral vaccine constituted of an attenuated strain derived from a human metapneumovirus.
    Type: Application
    Filed: December 12, 2019
    Publication date: February 24, 2022
    Inventors: Manuel ROSA-CALATRAVA, Guy BOIVIN, Julia DUBOIS, Mario Andres PIZZORNO, Olivier TERRIER, Aurélien TRAVERSIER
  • NEW ATTENUATED VIRUS STRAIN AND USE THEREOF AS A VACCINE
    Publication number: 20210283239
    Abstract: The present invention relates to an attenuated virus strain derived from a human metapneumovirus strain comprising the genome sequence represented by sequence SEQ ID NO. 1, said attenuated strain comprising one or more genetic modifications of said sequence SEQ ID NO. 1 attenuating the virulence of said strain.
    Type: Application
    Filed: July 12, 2019
    Publication date: September 16, 2021
    Inventors: Manuel ROSA-CALATRAVA, Guy BOIVIN, Julia DUBOIS, Mario Andres PIZZORNO, Olivier TERRIER, Marie-Eve HAMELIN, Marie-Helene CAVANAGH